The development of children with muscular dystrophy or myopathy involves complex physical changes that can differ significantly from those of their peers. These conditions primarily affect muscle tissue, but the systemic nature of the disorders and the medications used to manage them often have secondary effects on a child’s height and the timing of their sexual development. Specialist paediatric services in the United Kingdom prioritise the monitoring of growth and hormonal health to ensure that any delays or issues are identified early. By understanding the factors that influence these developmental milestones, families and clinical teams can better support the child’s overall health and well-being as they transition through adolescence.
What We’ll Discuss in This Article
- How muscle wasting conditions can naturally impact a child’s height and weight.
- The specific effect of long term corticosteroid use on bone growth.
- Why puberty may be delayed in teenagers with neuromuscular disorders.
- The importance of regular monitoring using specialist growth charts.
- Nutritional strategies to support healthy development during the teenage years.
- Hormonal treatments that may be considered by paediatric specialists.
Impact of Muscle Disorders on Physical Development
Muscular dystrophies and myopathies can lead to variations in growth patterns due to the reduced physical activity and the metabolic demands placed on the body by the underlying condition. Children with these disorders often follow a different growth trajectory, sometimes appearing shorter or having a different body composition than children without muscle weakness. This occurs because the body may prioritise essential functions over rapid physical growth when muscle tissue is undergoing continuous breakdown and repair.
In many forms of muscular dystrophy, such as Duchenne muscular dystrophy, the initial stages of growth may appear normal, but a slowing of height velocity is often noted as the child grows older. This is partially due to the progressive nature of the muscle weakness, which can lead to changes in posture and spinal alignment that affect height measurements. The NHS states that muscular dystrophy is a group of inherited genetic conditions that gradually cause the muscles to weaken, leading to an increasing level of disability over time.
Furthermore, reduced weight-bearing activity can affect the development of long bones. Without the regular stress placed on bones through walking and running, bone density and length may not increase at the expected rate. Specialist paediatric clinics use specific monitoring tools to track these changes, ensuring that any significant deviation from the child’s expected growth path is reviewed by an endocrinologist if necessary.
The Role of Corticosteroid Treatment in Growth
Corticosteroids are frequently prescribed to slow the progression of muscle weakness in certain dystrophies, but they are a primary factor in the growth suppression seen in many patients. While these medications are highly effective at prolonging the ability to walk and protecting heart and lung function, they also inhibit the production of growth hormones and affect the way bones develop. This often results in children being significantly shorter than their predicted height based on their parents’ stature.
The effect on growth is usually dose-dependent, meaning higher doses or longer durations of treatment lead to more pronounced height suppression. Because of this, UK clinical teams aim to find the “lowest effective dose” that maintains muscle strength while minimising the impact on the child’s height. Regular monitoring of height and weight is a standard part of every neuromuscular clinic appointment to track these side effects.
Despite the impact on height, the benefits of steroids in maintaining mobility and respiratory health often outweigh the concerns regarding short stature. To mitigate the effects, clinicians may discuss “steroid holidays” or alternative dosing schedules, such as intermittent rather than daily doses, depending on the specific type of dystrophy and the child’s response to the medication. Bone health is also supported through vitamin D and calcium supplementation to prevent the thinning of bones that can accompany steroid use.
Delayed Puberty and Hormonal Changes
Teenagers with progressive muscle conditions often experience a delay in the onset of puberty, which can be caused by the underlying illness or the side effects of medical treatments. Puberty is a complex biological process controlled by the brain and the endocrine system; when the body is managing a chronic and progressive condition, these hormonal signals can be delayed. This may result in the later development of secondary sexual characteristics, such as voice deepening in boys or the start of periods in girls.
Corticosteroids play a significant role here as well, as they can suppress the hormones responsible for triggering puberty. This delay can be distressing for teenagers who see their peers developing at a different rate. NICE clinical guidelines for neuromuscular conditions emphasize the importance of monitoring for delayed puberty and providing appropriate psychological and hormonal support.
In cases where puberty is significantly delayed, a paediatric endocrinologist may be consulted. They can perform blood tests to check hormone levels and may recommend a short course of testosterone or oestrogen to “kick-start” the process. This intervention is carefully timed to ensure it does not cause the growth plates in the bones to close too early, which would further limit the child’s eventual adult height.
Comparison of Growth Factors in Muscle Conditions
The following table summarises how different factors associated with myopathy and muscular dystrophy influence physical development.
| Factor | Primary Impact | Management Strategy |
| Genetic Condition | Metabolic demand and reduced activity. | Regular physical therapy and nutrition. |
| Corticosteroids | Significant suppression of height. | Dosing adjustments and bone support. |
| Reduced Mobility | Lower bone density and limb growth. | Weight-bearing exercises where safe. |
| Hormonal Suppression | Delayed onset of puberty. | Endocrine review and hormone therapy. |
| Nutrition | Risk of underweight or obesity. | Specialist dietitian monitoring. |
Nutritional Considerations for Healthy Development
Maintaining an optimal nutritional status is essential for supporting growth and managing the side effects of medications in children with muscle wasting conditions. Steroid treatment can lead to a significant increase in appetite, which, combined with reduced mobility, places the child at a high risk of rapid weight gain. Conversely, some children with myopathies may struggle to gain weight due to difficulties with chewing or swallowing, known as dysphagia.
A specialist dietitian is a core member of the neuromuscular multi-disciplinary team. They work with families to create a balanced eating plan that provides enough protein for muscle health and enough calories for growth, without leading to excessive weight gain. Excess weight can place additional strain on already weakened muscles and make mobility more difficult, further impacting the child’s physical development and independence.
Monitoring growth also involves assessing the child’s “body mass index” (BMI) using charts specifically adapted for children with disabilities. Because muscle weighs more than fat, and children with dystrophy lose muscle mass, standard BMI charts can sometimes be misleading. A dietitian will use skinfold measurements or other assessments to get a more accurate picture of the child’s body composition and nutritional needs.
Monitoring and Clinical Intervention Strategies
Regular and consistent monitoring is the most effective way to manage the impact of muscular dystrophy on growth and puberty. Paediatric specialist clinics in the UK typically see children every six months to record accurate measurements of height (or arm span if the child cannot stand) and weight. These measurements are plotted on growth charts to identify any “flattening” of the growth curve that might require investigation.
If growth or puberty is significantly delayed, the clinical team may recommend further tests, such as a “bone age” X-ray. This involves a simple scan of the hand and wrist to see how mature the bones are compared to the child’s actual age. If the bone age is significantly behind, it suggests there is still potential for growth, which can be reassuring for the family.
The transition from paediatric to adult services is also a key time for reviewing growth and hormonal health. As the child reaches their late teens, the focus shifts to ensuring that they have reached a healthy adult height and that their hormonal development is complete. This comprehensive follow-up ensures that the physical challenges of muscular dystrophy are managed proactively, allowing the young person to reach their full developmental potential.
Conclusion
Muscular dystrophies and myopathies affect growth and puberty through a combination of the underlying genetic condition and the side effects of essential treatments like corticosteroids. Children often experience slower height velocity and delayed sexual development, requiring regular monitoring by a specialist paediatric multi-disciplinary team. By using targeted nutritional support, hormonal reviews, and bone health monitoring, healthcare providers in the UK aim to minimise these developmental challenges. Proactive clinical management ensures that children and teenagers receive the necessary support to navigate these physical changes safely.
If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Why is my child shorter than their friends?
Children with muscle conditions often grow more slowly due to reduced physical activity and the effects of medications like steroids which can suppress growth.
Will my child ever go through puberty?
Yes, but it may be later than usual; if it is significantly delayed, a specialist can provide hormonal support to help the process along.
Are there growth charts for children with muscular dystrophy?
Specialist clinics often use adapted charts or arm span measurements to track growth more accurately when standing height is difficult to measure.
Do steroids always cause growth problems?
Most children on long-term daily steroids will have some degree of growth suppression, but doctors try to manage this by using the lowest effective dose.
Can diet help my child grow taller?
A good diet supports general health and bone strength, but it cannot override the growth-suppressing effects of steroids or the genetic condition.
Should I be worried if my teenager hasn’t started puberty by age 14?
It is worth discussing this with your neuromuscular team; they can refer you to an endocrinologist to check if any support is needed.
Does reduced mobility affect height?
Yes, because lack of weight-bearing can affect bone development, and changes in spinal alignment (like scoliosis) can also reduce a person’s measured height.
Authority Snapshot (E-E-A-T Block)
This guide was developed by the Medical Content Team and reviewed by Dr. Stefan Petrov, a UK-trained physician with extensive experience in general medicine and paediatric care. The information provided adheres to NHS and NICE standards for the management of neuromuscular conditions and the monitoring of childhood development. Our goal is to provide safe, factual, and evidence-based information to help families understand the complex relationship between muscle disease and physical growth.
